1Averette HE,Hoskins W,Nguyen HN.National surgery of ovarian carcinoma:a patient care evaluation of the American college of surgeons.Cancer,1973,71:1629-1638.
4Hainsworth JD,GrecoA.Paclitaxel administered by I-hour in-fusion prelin inary results of a phase Ⅰ/Ⅱ trial comparing two schedules.Cancer,1994,74 (4):1377.
5Connelly E,Markman M,Kennedy A.Paclitaxel delivered as a 3-hr in-fusion with cisplatine in patients with gynecologic cancers;unexected in-cidence of neurotoxicity.Gynecol oncol,1996,62:166-168.
2Levi F, Misset J L, P, rienza S, et ai. A chronopharmaco-logic phase [I clinical trial with 5-fluorouracil, folinieacid,and oxaliplatin using an ambulatory multichannelprogrammable pure. High antitumor effctiveness a-gainst metastatic eolorectal cancer EJJ. Cancer, 1992,69:893.
3Adelsberger H, Quasthoff S,Grosskreutz J, et al. The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons[J]. Eur J Pharmacol, 2000,406 (1) : 25.
4Perej EA,Vogel CL,Irwin DH,et al.Multicenter phase Ⅱ trial of weekly paclitaxel in women with metastatic breast cancer[J].J Clin Ocolo,2001,19(22):4216.
5Ajan JA.Treatment of patients with upper gastrointestinal carcinomas[J].Semin Oncol,1997,24(6):1972.
6Paul-B,Villejiuf.Oxaliplatin in practice[J].Br J Cancer,1998,77(4):4(suppl).
7Kim YH,Shin SW,Kim BS,et al.Paclitaxel,5-fluorouracil and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J].Cancer,1999,85(2):295.
